CD19 and acute lymphoblastic leukemia: In a meta-analysis of anti-CD19 CAR T-cell therapy in pediatric and adult patients with ALL, bone marrow involvement, disease status at the time of CAR T-cell infusion and presence of Philadelphia chromosome were not significantly associated with treatment outcomes [36].